[an error occurred while processing this directive]
综述

超滤在心肾综合征中的应用进展

  • 石晶 ,
  • 焦军东
展开
  • 1哈尔滨医科大学附属第二医院肾内科

收稿日期: 2021-03-08

  修回日期: 2021-05-17

  网络出版日期: 2021-08-05

Recent progresses in the application of ultrafiltration in cardiorenal syndrome

  • SHI Jing ,
  • JIAO Jun-Dong
Expand
  • 1Department of Nephrology, the Second Affiliated Hospital of Harbin Medical University, Harbin 150086, China

Received date: 2021-03-08

  Revised date: 2021-05-17

  Online published: 2021-08-05

摘要

【摘要】临床工作中,心脏疾病与肾脏疾病常常共同存在,相互影响,以单一器官为中心的治疗已经不足以解决这种多器官间相互作用的疾病,因此心肾综合征的概念被提出,液体超载和静脉充血是心肾综合征亟待解决的问题,超滤或许是静脉利尿剂无效后的最佳治疗策略。

本文引用格式

石晶 , 焦军东 . 超滤在心肾综合征中的应用进展[J]. 中国血液净化, 2021 , 20(08) : 551 -554 . DOI: 10.3969/j.issn.1671-4091.2021.08.011

Abstract

【Abstract】Heart disease and kidney disease are often co- existed and interacted each other clinically. The therapy focused on a single organ is inappropriate to treat the diseases with multiple organ interactions. The concept of cardiorenal syndrome is therefore proposed. In this syndrome, fluid overload and venous congestion are critical issues to be solved, and ultrafiltration may be the best strategy after unresponsiveness of intravenous diuretics.

参考文献

[1]Ronco C,Bellomo R,Kellum JA,et al.Acute kidney injury[J].Lancet,2019,394(10212):1949-1964.
[2]Morcos R, Lazar I, Kucharik M, et al.The Healthy, Aging, and Diseased Kidney: Relationship with Cardiovascular Disease[J].J Am Geriatr Soc,2021,69(2):539-546.
[3]Rangaswami J,Bhalla V, Blair JEA, et al.Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association[J].Circulation,2019,139(16):e840-e878.
[4]Ronco C,McCullough P, Anker SD, et al.Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative[J].Eur Heart J,2010,31(6):703-711.
[5]Costanzo MR.The Cardiorenal Syndrome in Heart Failure[J].Heart Fail Clin,2020,16(1):81-97.
[6]Latini R, Aleksova A, Masson S. Novel biomarkers and therapies in cardiorenal syndrome[J].Curr Opin Pharmacol,2016,(27):56-61.
[7]Bozkurt B, Kamat IS.Worsening renal function in acute decompensated heart failure:a bad sign,or maybe not?[J].Trans Am Clin Climatol Assoc,2019,130:41-50.
[8]Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines[J]. Circulation,2013,128(16):1810-1852.
[9]Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the heart failure association (HFA) of the ESC[J].Eur Heart J,2016,37(27):2129–2200.
[10]Felker GM, Lee KL, Bull DA,et al.Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med,2011;364(21):2066-2069.
[11]ter Maaten JM, Dunning AM, Valente MA, et al. Diuretic response in acute heart failure—an analysis from ASCEND-HF[J]. Am Heart J, 2015, 170(2):313-321.
[12]Valente MA, Voors AA, Damman K, et al.Diuretic response in acute heart failure: clinical characteristics and prognostic significance[J]. Eur Heart J,2014,35:1284–1293.
[13]Felker GM,Mentz RJ. Diuretics and ultrafiltration in acute decompensated heart failure[J].J Am Coll Cardiol,2012,59(24):2145-2153.
[14]Costanzo MR,Guglin ME, Saltzberg MT, et al.Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure[J].J Am Coll Cardiol,2007,49(6):675-683.
[15]Costanzo MR,Negoianu D,Jaski BE,et al.Aquapheresis versus intravenous diuretics and hospitalizations for heart failure[J].JACC Heart Fail,2016,4(2):95-105.
[16]Bart BA,Goldsmith SR,Lee KL,et al.Ultrafiltration in decompensated heart failure with cardiorenal syndrome[J].N Engl J Med,2012,367(24):2296-2304.
[17]Grodin JL,Carter S,Bart BA,et al.Direct comparison of ultrafiltration to pharmacological decongestion in heart failure: a per-protocol analysis of CARRESS-HF[J].Eur J Heart Fail,2018,20(7):1148-1156.
[18]Cruz DN,Schmidt-Ott KM,Vescovo G,et al.Pathophysiology of cardiorenal syndrome type 2 in stable chronic heart failure: workgroup statements from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI)[J]. Contrib Nephrol, 2013,182:17–36.
[19]Sahin E,G?k?ay Bek S,Eren N,et al.Usefulness of Peritoneal Ultrafiltration in Patients with Diuretic Resistant Heart Failure without End-Stage Renal Disease[J].Cardiorenal Med,2020,10(6):429-439.
[20]Grossekettler L,Schmack B,Brockmann C,et al.Benefits of peritoneal ultrafiltration in HFpEF and HFrEF patients[J].BMC Nephrol,2020,21(1):1787-1847.
[21]Costanzo MR, Negoianu D, Jaski BE, et al. Aquapheresis versus intravenous diuretics and hospitalizations for heart failure[J]. JACC Heart Fail,2016,4(2):95-105.
[22]Costanzo MR, Ronco C, Abraham WT, et al. Extracorporeal ultrafiltration for fluid overload in heart failure: current status and prospects for further research[J]. J Am Coll Cardiol,2017,69:2428–2445.
[23]?akal B,?zcan ?U,Omaygen? MO,et al.Value of Renal Vascular Doppler Sonography in Cardiorenal Syndrome Type 1[J].J Ultrasound Med,2021,40(2):321-330.
[24] Husain-Syed, F; Gr?ne, HJ; Assmus, B; et al.Congestive nephropathy: a neglected entity? Proposal for diagnostic criteria and future perspectives[J].ESC Heart Fail,2021,8(1):183-203.
[25]Di Lullo L,Bellasi A,Russo D,et al.Cardiorenal acute kidney injury: Epidemiology, presentation, causes, pathophysiology and treatment[J].Int J Cardiol,2017,227:143-150.
文章导航

/

[an error occurred while processing this directive]